Skip to main content
. 2012 Jun 1;31(1):53. doi: 10.1186/1756-9966-31-53

Table 3.

Response rates of primary chemotherapy for clear cell carcinoma

regimen author year response/ Number of patients, response rate
Conventional Platinum-based
Goff [28]
1996
1/6, 17%
Sugiyama [29]
2000
3/27, 11%
Ho [30]
2004
4/15, 27%
Takano [9]
2006
5/30, 17%
Taxane-Platinum
Enomoto [31]
2003
2/9, 22%
Ho [30]
2004
9/16, 56%
Utsunomiya [32]
2006
8/15, 53%
Takano [9]
2006
9/28, 32%
Irinotecan-cisplatin Takano [9] 2006 3/10, 30%